Enovis Corp
Enovis Corp (ENOV) Covered Calls
Enovis Corp trades in the Medical Devices industry with an IV Rank of 37.50%, average versus the past year. ENOV's highest covered call setup is the $30.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 17.79% out of the money with 28 days to expiration, a 19.75% return until expiration, and a 257.44% theoretical annualized return. Across the setups shown, annualized returns run from 65.12% to 257.44% at strikes between $30.00 and $45.00, with 28 to 392 days to expiration, as of Nov 20, 2026.
Read more
Running ENOV covered calls helps you generate income from Enovis Corp shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ENOV covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If ENOV stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ENOV covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ENOV covered call is worth writing.
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.
| 2026-12-18 | 28 | 30.00 | 17.79 | 0.50 | 0.80 | 503.00 | 19.75 | 257.44 | -1.96 | +0.24 | 902 | 0.30 |
| 2027-01-15 | 56 | 35.00 | 37.42 | 0.35 | 0.75 | 988.00 | 38.79 | 252.83 | -1.37 | +0.16 | 193 | 0.40 |
| 2027-01-15 | 56 | 30.00 | 17.79 | 0.90 | 1.50 | 543.00 | 21.32 | 138.96 | -3.53 | +0.32 | 1,149 | 0.60 |
| 2027-03-19 | 119 | 35.00 | 37.42 | 0.10 | 2.90 | 963.00 | 37.81 | 115.97 | -0.39 | +0.29 | 0 | 2.80 |
| 2027-04-16 | 147 | 35.00 | 37.42 | 1.00 | 3.80 | 1053.00 | 41.34 | 102.65 | -3.93 | +0.36 | 3,362 | 2.80 |
| 2027-07-16 | 238 | 40.00 | 57.05 | 1.35 | 3.60 | 1588.00 | 62.35 | 95.62 | -5.30 | +0.33 | 0 | 2.25 |
| 2027-12-17 | 392 | 45.00 | 76.68 | 1.00 | 3.90 | 2053.00 | 80.60 | 75.05 | -3.93 | +0.31 | 6 | 2.90 |
| 2027-03-19 | 119 | 30.00 | 17.79 | 1.60 | 3.70 | 613.00 | 24.07 | 73.82 | -6.28 | +0.43 | 0 | 2.10 |
| 2027-07-16 | 238 | 35.00 | 37.42 | 1.50 | 4.00 | 1103.00 | 43.31 | 66.41 | -5.89 | +0.38 | 0 | 2.50 |
| 2027-04-16 | 147 | 30.00 | 17.79 | 2.15 | 3.40 | 668.00 | 26.23 | 65.12 | -8.44 | +0.44 | 2,494 | 1.25 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV Rank37.50% Moderate
- Market cap (M$)1,469
- 52 weeks high-19.55%
- 52 weeks low52.51%
- Analyst recommendationStrong Buy
1.23 - Target price$37.83
48.53% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-05
- P/E—
- Future P/E7.35
- EPS (ttm)-9.19
- EPS growth next 5 years4.86%
As of Nov 20, 2026